Introduction {#s001}
============

Remote patient monitoring (RPM) has enhanced clinicians\' ability to monitor and manage patients in nontraditional healthcare settings. RPM uses digital technologies to collect health data from individuals in one location, such as a patient\'s home, and electronically transmit the information to healthcare providers in a different location for assessment and recommendations.^[@B1]^ More specifically, noninvasive technologies are now commonly being integrated into disease management strategies to provide additional patient information, with the goal of improving healthcare decision-making.^[@B2],[@B4]^

Digital technologies are continually being adopted as an additional method for healthcare systems to increase patient contact and augment the practice of preventive medicine.^[@B1],[@B2],[@B9]^ Healthcare professionals have the ability to share health data with remotely based clinical experts for consultation, saving time and expense for practitioners and patients, and actively managing treatments for those with chronic conditions.^[@B1]^ Health data are typically transmitted to healthcare professionals in facilities such as monitoring centers in primary care settings, hospitals and intensive care units, skilled nursing facilities, and centralized management programs, among others.^[@B1],[@B4]^ Diversity exists in the design of noninvasive digital technologies for RPM as well as in the role of the patient. For example, some noninvasive digital devices may be automated to capture and transmit health data without any action from the patient (i.e., biosensor or wearable devices); whereas, other technologies may require the patient to submit their own health data through a secure Web site, smartphone, or personal digital assistant (PDA).^[@B1],[@B4]^ Common clinical data captured by these technologies include vital signs, weight, blood pressure, oxygen levels, and heart rate.^[@B2],[@B4],[@B10],[@B11]^

Publications to date have used different terminology to capture the essence of RPM (e.g., *telehealth*, *telemedicine*, *e-Health*) and the overall language used to describe RPM is inconsistent and still being established.^[@B1],[@B9],[@B12],[@B13]^ Inconsistency in terminology may be attributed to the evolution of this particular group of technologies. As science and technology continue to advance, RPM has transitioned from capturing remote patient data through telephone interviews and videoconferencing to utilizing automated devices (e.g., biosensor devices) and focusing on particular patient populations (e.g., chronic diseases).^[@B11]^ A systematic review of the term *e-health* identified 51 unique definitions for the term with no clear consensus on the meaning.^[@B12]^ Another review noted the term *telemedicine* is used interchangeably with the term *e-health* (i.e., communication networks used to deliver healthcare services or health information from one geographical location to another).^[@B11],[@B13],[@B14]^ Definitions may also be based on the patient\'s health condition and how RPM technologies gather and send health data back into the health system.^[@B4],[@B12]^ In light of these variances, this study focused on a patient-centered definition of RPM: an ambulatory, noninvasive digital technology used to capture patient data in real time and transmit health information for assessment by a health professional or for self-management.

While many RPM interventions have been adopted on a small scale, large-scale implementation continues to be a challenge. To gain clinical credibility, many RPM technologies are tasked with the "burden of evidence" by publishing in the peer-reviewed literature.^[@B13],[@B15]^ Due to the relative infancy of this realm of healthcare, we aim to summarize the current level of evidence to date by completing a comprehensive systematic literature review, and applying the same level of rigor required in the evaluation of other healthcare interventions. Hence, the objective of this systematic review was to identify studies reporting the use of patient-centered RPM via noninvasive digital technologies in the past decade and describe the key trends, including patient and clinical characteristics and health-related findings by these technologies.

Materials and Methods {#s002}
=====================

A search was conducted in EMBASE (2005--2015) and Ovid MEDLINE (January 1, 2005 to September 15, 2015). The search strategy is provided in [Supplementary Table S1](#SD1){ref-type="supplementary-material"} (Supplementary Data are available online at [www.liebertpub.com/tmj](www.liebertpub.com/tmj)). An extensive list of search terms was used to identify all appropriate technologies.

The study selection criteria were specified based on the Population, Intervention, Comparator, Outcomes, Timeframe, and Study Design (PICOTS) format.^[@B16]^ The patient population included individuals enrolled in a health-related study where the intervention(s) was consistent with our definition of RPM via noninvasive digital technology. We subcategorized interventions based on technology, using the following definitions: • Any smartphone or PDA device (or associated software/application/text messaging) that is used to transmit patient data to the physician/researcher.• Any wearable device worn or placed on a body part to record a particular physiological change (e.g., respiratory rate sensors or blood pressure monitors).• Any biosensor device for recording data from biological or chemical reactions (e.g., pulse oximeters or spirometers).• A computerized system where data are entered by the patient over an internet connection.• Multiple components containing more than one technology category above (e.g., biosensor device and computerized system^[i](#fn1){ref-type="fn"}^).

The comparators for the review included either standard care or other technologies used to collect patient health data. Outcomes included any health-related outcomes captured by the RPM technology as well as the associated costs (if reported). Study designs included both randomized controlled trials (RCTs), observational studies, and systematic reviews published from January 1, 2005 to September 15, 2015; protocols, nonsystematic reviews, case studies, commentaries, and letters or editorials were excluded.

Specific exclusion criteria were applied to narrow the focus of selected studies to those reporting patient health data captured via noninvasive RPM digital technologies. The predefined exclusion criteria included the following: interventions with invasive or implantable digital technology (e.g., implantable cardiac defibrillators, blood glucose monitors) or nondigital technology (i.e., landline telephone as the only source of data transmission); no remote monitoring of patient data (e.g., treatment algorithm); no real-time data capture (i.e., participants can only access the device at prescheduled times); and if the data acquired by a device were limited to only patient-reported outcomes, survey responses, or drug performance/adherence.

Study Selection Process {#s003}
-----------------------

All citations identified from the literature search were screened for relevance. The first level of screening involved an assessment of citation abstracts for relevance by a single reviewer, based on specific exclusion criteria. Two reviewers were consulted to determine whether any uncertain abstracts were to be included. The second level of screening involved a review of the full-text articles identified from the level one screening to determine if these studies met the predefined inclusion and exclusion criteria listed above. This was undertaken by a single reviewer with four additional reviewers consulted to determine whether any uncertain articles were to be included or excluded based on the study selection criteria.

Quality Appraisal of Literature {#s004}
-------------------------------

The quality appraisal process utilized the Critical Appraisal Skills Programme (CASP) checklists for RCTs, cohort studies, and case--control study designs.^[@B17]^ The CASP checklists evaluate the trustworthiness and relevance of studies based on three key areas: study validity (bias), study results (clinical importance and degree of certainty), and relevance (generalizability to patient or population of interest). Quality appraisal was conducted by two independent reviewers for included studies. Instances of disagreement between the two reviewers were identified and evaluated by a third reviewer. Observational, cross-sectional studies are not supported by a CASP quality appraisal checklist. Therefore, the findings from cross-sectional studies should be interpreted with caution.^[@B18]^

Data Collection/Study Variables {#s005}
-------------------------------

Due to the high degree of variability in the study designs and objectives, information was extracted to descriptively assess trends and frequencies of the predefined study variables, including the following: technology category, country setting, patient characteristics, and feedback loop. The health outcomes reported by the included studies were broadly defined as positive, negative, or neutral health outcomes, depending on the impact of the intervention on the study outcomes of interest. Clinical or statistical significance was required for a positive categorization as many studies reported only descriptive findings without any supporting statistical analysis. Cost outcomes were also collected, if reported.

Results {#s006}
=======

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram ([*Fig. 1*](#f1){ref-type="fig"}) graphically represents the citations reviewed, included, or excluded during the course of the systematic review process.^[@B19]^ The database search identified 345 articles with two additional articles identified from manual searching. Of the 347 articles identified, 62 articles met the study inclusion criteria. Details of each of these studies can be found in [*Table 1*](#T1){ref-type="table"}.

![PRISMA diagram of study selection process. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.](fig-1){#f1}

###### 

Table of Study Details

  FIRST AUTHOR, YEAR                                         COUNTRY          DISEASE CATEGORY/DISEASE STATE                                    STUDY DESIGN/STUDY DURATION                        SAMPLE SIZE (*N*)   AGE GROUPS (YEARS)   TECHNOLOGY CATEGORY/DEVICE INFORMATION                                                                                                                                                                    RESULTS    FEEDBACK LOOP/END USER                   FUNDING BODY
  ---------------------------------------------------------- ---------------- ----------------------------------------------------------------- -------------------------------------------------- ------------------- -------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- ---------------------------------------- -------------------------------------------
  Allard, 2014                                               France           Neurological/Dementia                                             Cohort/September 2007 to March 2009                60                  ≥65                  Smartphones, PDAs/Mobile assessments of daily life experiences                                                                                                                                            Positive   Physician                                Government
  Allen, 2013                                                United States    Weight management/Obesity                                         RCT/24 weeks                                       68                  ≥20                  Smartphones, PDAs/Weight loss application                                                                                                                                                                 Positive   Physician and self/Patient               Academic
  Anton, 2012                                                United States    Weight management/Obesity                                         RCT/104 weeks                                      671                 ≥20                  Computerized system/Web-based computerized tracking                                                                                                                                                       Positive   Counselors                               Government
  Barnett, 2011                                              United States    Substance abuse/Alcohol abuse                                     Observational/3 weeks                              13                  ≥20                  Multiple components/Alcohol monitoring bracelet                                                                                                                                                           Positive   Physician                                NR
  Bombardini, 2009                                           Italy            Cardiovascular/Various                                            Cohort/One session                                 172                 ≥20                  Wearable device/Accelerometer                                                                                                                                                                             Positive   Physician                                Academic
  Carr, 2013                                                 United States    Weight management/Obesity, overweight, and sedentary              RCT/12 weeks                                       40                  ≥20                  Multiple components/Activity monitor; pedal machine; motivational Web site; pedometer                                                                                                                     Positive   Self/Patient                             Academic
  Chau, 2012                                                 China            Respiratory/COPD                                                  RCT/8 weeks                                        40                  ≥65                  Multiple components/A telecare device kit to monitor oxygen saturation, pulse rate, and respiration rate to transmit data to an online network                                                            Neutral    Nurse and Physician                      NR
  Dansky, 2008                                               United States    Cardiovascular/Heart failure                                      RCT/120 days                                       284                 ≥65                  Multiple components/Telehomecare system through a standard modem, linking a central station to remote units in homes or other settings                                                                    Positive   Nurse                                    Nonprofit foundation
  De San Miguel, 2013                                        Australia        Respiratory/COPD                                                  RCT/24 weeks                                       71                  ≥20                  Multiple components/HealthHUB (Docobo Ltd., Bookham, Surrey, United Kingdom). Patients measured vital signs and these were transmitted automatically through telephone to a secure Web site               Neutral    Nurse                                    Government
  Dellaca, 2011                                              Spain            Sleep disorders/Sleep apnea                                       Observational study/One night                      20                  40--64               Wearable/Telemetric unit connected to CPAP                                                                                                                                                                Positive   Sleep technician                         Government
  DeVito Dabbs, 2009                                         United States    Respiratory/Lung transplant                                       RCT/8 weeks                                        30                  40--64               Smartphones, PDAs/Health tracking application                                                                                                                                                             Positive   Physician                                NR
  Dinesen, 2012                                              Denmark          Respiratory/COPD                                                  RCT/16 weeks                                       111                 ≥20                  Biosensor/Spirometry                                                                                                                                                                                      Positive   Physician and Nurse                      NR
  Dirienzo, 2007                                             United States    Neurological/Cerebral palsy                                       Cohort/10 weekly 20-min riding sessions            8                   \<20                 Wearable device/Pulse rate sensor and transmitter                                                                                                                                                         Neutral    NR                                       NR
  Dorsch, 2015                                               International    Neurological/Stroke rehabilitation                                RCT/15 months                                      125                 ≥20                  Wearable device/Three sets of triaxial accelerometers                                                                                                                                                     Neutral    Physician                                Government
  Faurholt-Jepsen, 2015 (*Journal of Affective Disorders*)   Denmark          Psychological/Bipolar type 1 or 2                                 RCT/310 days                                       33                  21--39               Smartphones, PDAs/Android smartphone with the MONARCA system installed and instructed to use the system for daily electronic self-monitoring                                                              Neutral    Self/Patient                             Nonprofit foundation
  Faurholt-Jepsen, 2015 (*Bipolar Disorders*)                Denmark          Psychological/Bipolar type 1 or 2                                 RCT/6 months                                       91                  ≥20                  Smartphones, PDAs/Android smartphone with the MONARCA system installed and instructed to use the system for daily electronic self-monitoring                                                              Neutral    Researcher                               Nonprofit foundation
  Fox, 2012                                                  Canada           Sleep disorders/Obstructive sleep apnea                           RCT/3 months                                       75                  ≥20                  Wearable device/CPAP device with modem                                                                                                                                                                    Positive   Researcher                               Industry
  Franc, 2014                                                France           Metabolic disorders/Type 1 diabetes                               RCT/6 months                                       113                 ≥20                  Smartphone, PDAs/Software uploaded into the smartphone                                                                                                                                                    Positive   Medical staff, caregiver                 Industry
  Fukuoka, 2015                                              United States    Metabolic disorders/Weight management                             RCT/5 months                                       61                  40--64               Smartphones/PDAs/Mobile phone-based program                                                                                                                                                               Positive   Self/Patient                             Government and academic
  Green, 2008                                                United States    Cardiovascular/Hypertension                                       RCT/12 months                                      730                 ≥20                  Multiple components/Patient Web services, home BP monitoring, and pharmacist-assisted care                                                                                                                Positive   Pharmacist                               Government
  Greene, 2013                                               United States    Weight management/Obesity                                         RCT/6 months                                       349                 ≥20                  Multiple components/Online social network; accelerometer; scale                                                                                                                                           Positive   Self/Patient and online social network   Private sector
  Guihot, 2007                                               France           Respiratory/Late-onset noninfectious pulmonary complications      Observational/Median 17 months (4--41) follow-up   37                  ≥20                  Biosensor device/Spirometer                                                                                                                                                                               Positive   Physician                                NR
  Hoefman, 2007                                              Netherlands      Cardiovascular/Arrhythmia                                         Observational/30 days                              127                 ≥20                  Biosensor/Loop recorder, ECG                                                                                                                                                                              Neutral    Cardiologist                             NR
  Jan, 2007                                                  Taiwan           Respiratory/Allergies, asthma                                     RCT/12 weeks                                       164                 \<20                 Multiple components/Electronic peak flow meter and Web site                                                                                                                                               Positive   Physician                                Government
  Jehn, 2013                                                 Germany          Respiratory/COPD                                                  RCT/9 months                                       62                  \>20                 Multiple components/Mobile medical assistant; spirometer; measuring wheel; accelerometer                                                                                                                  Positive   Nurse                                    Government
  Jurgens, 2012                                              Germany          Other/Primary open-angle glaucoma                                 Observational/6 months                             70                  ≥20                  Multiple components/A self-tonometer and BP oscillometric device                                                                                                                                          Neutral    Ophthalmologist (other)                  Government
  Kearney, 2009                                              United Kingdom   Cancer/Chemotherapy-related toxicity                              RCT/12--16 weeks                                   112                 40--64               Smartphones/PDAs/ASyMS^©^ mobile phone group completed a symptom questionnaire to measure the incidence, severity, and distress associated with each symptom                                              Neutral    Physician                                Academic
  Koff, 2009                                                 United States    Respiratory/COPD                                                  RCT/12 weeks                                       40                  ≥20                  Multiple components/Health monitoring system; pulse oximeter; FEV1 monitor; pedometer                                                                                                                     Positive   A registered respiratory therapist       Academic
  Lee, 2013                                                  Korea            Cardiovascular/Acute coronary syndrome                            RCT/12 weeks                                       55                  40--64               Wearable device/Wireless monitoring to check heart rates by electrocardiography                                                                                                                           Positive   Researcher                               Industry and Government
  Logan, 2007                                                Canada           Metabolic disorders/Type 2 diabetes, Hypertension                 Cohort/16 weeks                                    31                  ≥20                  Multiple components/Commercially available Bluetooth-enabled BP monitoring device                                                                                                                         Positive   Physician                                Government
  Logan, 2012                                                Canada           Metabolic disorders/Type 2 diabetes                               RCT/1 year                                         110                 \>20                 Multiple components/Commercially available Bluetooth-enabled BP monitoring device                                                                                                                         Positive   Physician                                Nonprofit foundation
  Luley, 2014                                                Germany          Metabolic disorders/Type 2 diabetes, Obesity, Weight management   RCT/6 months                                       70                  40--64               Multiple components/Health monitoring system, including weighing scales and accelerometer                                                                                                                 Positive   Self/Patient                             NR
  Mehring, 2013                                              Germany          Weight management/Obesity                                         RCT/12 weeks                                       186                 40--64               Computerized system/Web site program for individual coaching                                                                                                                                              Positive   Physician or Nurse                       Private Sector
  Mendelson, 2014                                            France           Sleep disorders/Obstructive sleep apnea                           RCT/16 weeks                                       107                 ≥20                  Multiple components/CPAP and smartphone to transmit clinical information                                                                                                                                  Positive   Physician                                Private Sector
  Minassian, 2010                                            United States    Psychological/Bipolar type 1 or 2, schizophrenia                  Observational/Three 5-min epochs                   28                  21--39               Wearable device/Upper body garment ECG                                                                                                                                                                    Neutral    NR                                       Government; Nonprofit organization
  Nollen, 2014                                               United States    Weight management/Obesity                                         RCT/12 weeks                                       51                  \<20                 Smartphones, PDAs/Handheld computer program                                                                                                                                                               Neutral    Self/Patient                             Government
  Olson, 2007                                                United States    Cardiovascular/Palpitations, presyncope, syncope                  Observational/July 2003 to August 2004             122                 40--64               Biosensors/Sensor records two ECG channels with a separate monitoring device                                                                                                                              Positive   Physician                                NR
  Palmas, 2008                                               United States    Metabolic disorders/Type 2 diabetes                               Cohort/mean follow-up time 32.1 ± 8.4 months       392                 ≥65                  Wearable devices/Oscillometric device                                                                                                                                                                     Neutral    Physician                                Government
  Pedone, 2015                                               Italy            Cardiovascular/Heart failure                                      RCT/6 months                                       96                  ≥65                  Multiple components/Sphygmomanometer, a scale: pulse oximeter                                                                                                                                             Positive   Physician                                NR
  Pedone, 2013                                               Italy            Respiratory/COPD                                                  RCT/9 months                                       99                  ≥65                  Multiple components/Telemonitoring system: wearable device, pulse-oximeter, cellular telephone                                                                                                            Positive   Physician                                Government
  Piga, 2014                                                 Italy            Other/Systemic sclerosis and rheumatoid arthritis                 RCT/12 weeks                                       40                  40--64               Biosensor/Portable briefcase includes sensor tools                                                                                                                                                        Positive   Physician                                Government
  Rasmussen, 2005                                            Denmark          Respiratory/Asthma                                                RCT/6 months                                       300                 ≥20                  Computerized system/Internet-based asthma management tool                                                                                                                                                 Positive   Physician                                Academic, Industry, and Private
  Rogers, 2014                                               United States    Psychological/Trichotillomania                                    RCT/10 weeks                                       60                  ≥20                  Computerized system/Patient Web site                                                                                                                                                                      Positive   Self/Patient                             Government
  Ryan, 2012                                                 United Kingdom   Respiratory/Asthma                                                RCT/6 months                                       288                 ≥20                  Smartphones/PDAs/Asthma phone application                                                                                                                                                                 Neutral    Nurse                                    Nonprofit organization
  Salarian, 2007                                             Switzerland      Neurological/Parkinson\'s disease                                 Case-control/∼4--5 min                             20                  ≥20                  Wearable device/Biaxial accelerometer, gyroscope, data logger                                                                                                                                             Positive   Not defined                              Nonprofit foundation
  Scalvini, 2005                                             Italy            Cardiovascular/Palpitations                                       RCT/7 days (or two recordings)                     310                 40--64               Multiple components/One-lead ECG trace sent it to telemedicine center                                                                                                                                     Positive   Nurse or cardiologist                    NR
  Shane-McWhorter, 2014                                      United States    Metabolic disorders/Type 2 diabetes, hypertension                 Observational/Average duration 7 months            109                 40--64               Multiple components/One of two telemonitoring delivery methods: touch-screen or an IVR system both included BP monitor heart rate monitoring and patients were provided a digital scale                   Positive   Pharmacist, Healthcare educators         Government
  Shany, 2010                                                Australia        Respiratory/COPD                                                  RCT/12 months                                      80                  ≥20                  Multiple components/A home monitor comprising a fixed portal, which was used to record daily physiological parameters as well as enter weight, body temperature, and blood glucose levels (if diabetic)   Neutral    Nurse                                    NR
  Spring, 2013                                               United States    Weight management/Obesity                                         RCT/12 months                                      69                  ≥20                  Smartphones/PDAs/PDA to record food intake, weight, and physical activity                                                                                                                                 Positive   A behavioral coach (Counselor)           Government
  Stone, 2010                                                United States    Metabolic disorders/Type 2 diabetes                               RCT/3 months                                       150                 ≥20                  Biosensor/Home telemonitoring device with monitoring of blood glucose, blood pressure, and weight                                                                                                         Positive   Nurse                                    Government
  Su, 2014                                                   Taiwan           Neurological/Parkinson\'s disease                                 Case series/One session                            5                   ≥65                  Wearable device/Triaxial accelerometer                                                                                                                                                                    Neutral    Researchers                              Nonprofit organization
  Tabak, 2012                                                Netherlands      Respiratory/COPD                                                  Cohort/4 days                                      39                  ≥20                  Multiple components/Activity sensor and smartphone were worn on the subject\'s belt                                                                                                                       Neutral    Not defined                              NR
  Thomas, 2015                                               United States    Weight management/Obesity                                         RCT/6 months                                       154                 ≥20                  Computerized system/Weight-loss Web site                                                                                                                                                                  Positive   Physician                                Government
  van der Meer, 2009                                         Netherlands      Respiratory/Asthma                                                RCT/12                                             200                 ≥20                  Multiple components/Spirometer and Web site                                                                                                                                                               Positive   Asthma nurse                             Nonprofit organization
  Wakefield, 2011                                            United States    Metabolic disorders/Type 2 diabetes, Hypertension                 RCT/52 weeks                                       302                 ≥20                  Multiple components/The home telehealth device to enable data transmission                                                                                                                                Positive   Nurse                                    Government
  Wakefield, 2012                                            United States    Metabolic disorders/Type 2 diabetes, hypertension                 RCT/52 weeks                                       302                 ≥20                  Multiple components/The home telehealth device to enable data transmission                                                                                                                                Positive   Nurse                                    Government
  Wang, 2012                                                 United States    Weight management/Obesity                                         RCT/12 months                                      210                 ≥20                  Smartphones/PDAs/PDA recorded food entry and physical activity                                                                                                                                            Positive   Self/Patient                             Government
  Webber, 2013                                               United States    Weight management/Obesity                                         RCT/12 weeks                                       50                  ≥20                  Computerized system/Online self-monitoring                                                                                                                                                                Positive   Self/Patient                             Nonprofit organization and private sector
  Widmer, 2015                                               United States    Cardiovascular/Cardiovascular rehabilitation                      Cohort/3 months                                    42                  ≥20                  Multiple components/Personal health assistant through online and smartphone-based platforms                                                                                                               Positive   Self/Patient                             Nonprofit foundation
  Wijsman, 2013                                              Netherlands      Weight management                                                 RCT/13 weeks                                       235                 ≥20                  Multiple components/Accelerometer-based activity monitor, a personal Web site, and a personal e-coach                                                                                                     Positive   Self/Patient and e-coach (counselor)     Nonprofit organization and private sector
  Woodend, 2008                                              Canada           Cardiovascular/Heart failure and Angina                           RCT/12 weeks                                       249                 ≥20 y                Biosensor/Transmission of ECG                                                                                                                                                                             Positive   Nurse                                    Nonprofit foundation and industry.
  Zheng, 2014                                                China            Cardiovascular/Healthy control subjects                           Case series/24 h                                   10                  21--39               Wearable device/Wearable ECG: two e-textile electrodes were sewed in the armband and one placed on the right side of the thorax                                                                           Positive   Researcher                               Government

COPD, chronic obstructive pulmonary disease; CPAP, continuous positive airway pressure; ECG, electrocardiogram; FEV, forced expiratory volume; IVR, interactive voice response; NR, not reported; PDA, personal digital assistant; RCT, randomized controlled trial.

Quality Appraisal {#s007}
-----------------

The majority of the 62 studies included in the systematic review used an RCT design. Most of the RCT studies (*N* = 44) received positive responses to the CASP checklist criteria, although one of the criteria regarding blinding of patients and study personnel (to the RPM intervention) was reported by only 10 of the RCTs. The cohort studies (*n* = 7) and case--control study (*n* = 1) also had primarily positive responses after being reviewed by the CASP checklists, whereas the remaining studies (*n* = 10) were observational, cross-sectional study designs with no quality appraisal performed.

Overall Trends: RPM Noninvasive Digital Technology {#s008}
--------------------------------------------------

RPM with noninvasive digital technologies is becoming more available for monitoring and collecting patient healthcare information. [*Figure 2*](#f2){ref-type="fig"} illustrates the number of published RPM with noninvasive digital technology studies, by technology category, included in the systematic review over the last decade. Funding of included studies were mainly from government and nonprofit organizations.

![Identified RPM via Noninvasive Digital Technology Studies (January 1, 2005 to September 15, 2015) ^a^Multiple components refer to studies containing more than one technology category. ^b^Searches ended September 15, 2015. PDAs, personal digital assistants; RPM, remote patient monitoring.](fig-2){#f2}

The breakdown of technology categories included in the current systematic review is illustrated in [*Figure 3*](#f3){ref-type="fig"}. Overall, 12 studies were identified using a smartphone or PDA,^[@B20]^ 11 studies utilized wearable devices,^[@B32]^ 7 studies utilized biosensor devices,^[@B43]^ 6 studies included computerized systems,^[@B50]^ and 26 studies comprised multiple technologies.^[ii](#fn2){ref-type="fn"},[@B56]^

![RPM through Noninvasive Digital Technologies ^a^Multiple components refer to studies containing more than one technology category.](fig-3){#f3}

The patient populations of the included studies were predominantly adults, 20 years of age or older, with only 5% of studies including children or adolescents (\<20 years of age). Many studies recruited specific adult age groups: young adults between 21 and 39 years of age (5% of studies), older adults between 40 and 64 years of age (18%), and seniors ≥65 years old (10%). Overall, the majority (61%) of studies included a mix of younger and older adult populations. The clinical characteristics of the included studies showed a dominance of chronic disease populations. The most prevalent conditions included the following: 23% respiratory diseases (e.g., asthma), 18% weight management, 18% metabolic diseases (e.g., type 1 and 2 diabetes), and 16% cardiovascular diseases (e.g., heart failure.)

All studies included elements of a feedback loop, however, the end user or recipient of the captured data varied greatly across the included studies. The majority included physicians or nurses as the main recipient of patient health data (31% and 16%, respectively). In 18% of studies, the end user of the captured data was the patient. These studies primarily utilized smartphones/PDAs or computerized systems to enable self-monitoring of patient lifestyle behaviors (i.e., caloric intake and exercise).

Key Trends by Noninvasive Digital Technology {#s009}
--------------------------------------------

The key trends for each of the technology categories are listed in [*Table 2*](#T2){ref-type="table"}, diversity among the technologies was shown across all of the study variables. Only studies on computerized systems were found to be primarily conducted within the United States, and studies on smartphones/PDAs were evenly split between U.S. and non-U.S. settings. In terms of clinical and patient characteristics, patients with respiratory disorders/diseases and metabolic conditions were primarily monitored through multicomponent interventions. In contrast, weight management was mainly monitored through computerized systems, and patients with cardiovascular diseases were mainly monitored using biosensor devices.

###### 

Key Trends by Noninvasive Digital Technology (Number of Studies)

                                                    SMARTPHONES/PDAS   WEARABLE DEVICES   BIOSENSOR DEVICES   COMPUTERIZED SYSTEM   MULTIPLE COMPONENTS
  ------------------------------------------------- ------------------ ------------------ ------------------- --------------------- ---------------------
  Number of studies, *N* = 62, *n* (%)              12 (19)            11 (18)            7 (11)              6 (10)                26 (42)
  Country, *n* (%)                                                                                                                  
   Non-U.S.^[a](#tf2){ref-type="table-fn"}^         6 (50)             7 (64)             5 (71)              2 (33)                16 (62)
   U.S.                                             6 (50)             4 (36)             2 (29)              4 (67)                10 (38)
  Disease category, *n* (%)                                                                                                         
   Cancer                                           1 (8)              ---                ---                 ---                   ---
   Cardiovascular                                   ---                3 (27)             3 (43)              ---                   5 (19)
   Metabolic disorders                              2 (17)             1 (9)              1 (14)              ---                   6 (23)
   Neurological                                     1 (8)              4 (36)             ---                 ---                   ---
   Psychological                                    2 (17)             1 (9)              ---                 1 (17)                ---
   Respiratory                                      2 (17)             ---                2 (29)              1 (17)                9 (35)
   Sleep disorders                                  ---                2 (18)             ---                 ---                   1 (4)
   Substance abuse                                  ---                ---                ---                 ---                   1 (4)
   Weight management                                4 (33)             ---                ---                 4 (67)                3 (12)
   Other/Multiple^[b](#tf3){ref-type="table-fn"}^   ---                ---                1 (14)              ---                   1 (4)
  Age category, *n* (%)                                                                                                             
   \<20 years old                                   1 (8)              1 (9)              ---                 ---                   1 (4)
   21--39 years old                                 1 (8)              2 (18)             ---                 ---                   ---
   40--64 years old                                 3 (25)             2 (18)             2 (29)              1 (17)                3 (12)
   ≥65 years old                                    1 (8)              1 (9)              ---                 ---                   4 (15)
   \>20 years old^[c](#tf4){ref-type="table-fn"}^   6 (50)             4 (36)             5 (71)              5 (83)                18 (69)
   Not reported                                                        1 (9)                                                         
  Feedback loop, *n* (%)                                                                                                            
   Counselors                                       1 (8)              ---                ---                 1 (17)                ---
   Nurse                                            1 (8)              ---                2 (29)              ---                   7 (27)
   Pharmacist                                       ---                ---                ---                 ---                   1 (4)
   Physician                                        3 (25)             3 (27)             4 (57)              2 (33)                7 (27)
   Researchers                                      1 (8)              4 (36)             ---                 ---                   ---
   Self/Patient                                     4 (33)             ---                ---                 2 (33)                5 (19)
   Not reported                                     ---                3 (27)             ---                 ---                   1 (4)
   Other^[d](#tf5){ref-type="table-fn"}^            2 (17)             1 (9)              1 (14)              1 (17)                5 (19)
  Results, *n* (%)                                                                                                                  
   Negative                                         ---                1 (9)              ---                 ---                   ---
   Neutral                                          5 (42)             5 (45)             1 (14)              ---                   5 (19)
   Positive                                         7 (58)             5 (45)             6 (86)              6 (100)               21 (81)

Non-U.S. countries included Canada, China, Taiwan, Korea, and several European countries (France, Italy, Spain, Denmark, Netherlands, Germany, Switzerland, and the United Kingdom).

Disease category: "Other/multiple" includes patients with leg ulcers, glaucoma, systemic sclerosis, and rheumatoid arthritis.

Age category: "Adults (\>20 years)" refers to studies with more than one adult age category included (e.g., 35--70 years old).

Feedback loop: "Other" refers to multiple categories of feedback loop categories (i.e., physician and researcher), other healthcare professionals not listed, caregivers, or studies which did not explicitly report the end-user of the data.

The vast majority of studies including adults ≥20 years (incorporating both younger and older adult populations), primarily utilizing multiple-component technologies. Of the three studies including child/adolescent populations, multicomponent interventions, smartphones/PDAs, or wearable devices were used. Similarly, the three studies that specifically recruited young adults (20--39 years) employed smartphones/PDAs or wearable devices. In terms of the feedback loop, smartphones/PDAs and computerized systems most often used the patient as the primary recipient of health data. Wearable devices most often transmitted data to study researchers; whereas biosensor devices and multicomponent interventions predominantly transmitted data to physicians or nurses. Although most of the studies included were RCT designs, the health outcomes reported were diverse and mainly descriptive in nature; therefore, outcomes were classified as primarily positive, negative, or neutral to understand the overall trends. Overall, most studies reported positive health outcomes,^[iii](#fn3){ref-type="fn"}^ including the computerized technologies (100%), followed by biosensor devices (86%), multicomponent interventions (81%), and smartphones/PDAs (58%). Only studies on wearables devices found an even split between positive and neutral outcomes.^[iv](#fn4){ref-type="fn"}^ Of the six studies that reported cost associated with utilizing an RPM technology, these were also neutral or positive compared with the control group (data not shown).^[@B29],[@B43],[@B60],[@B66],[@B69],[@B81]^

Discussion {#s010}
==========

RPM is an evolving and growing area of healthcare innovation in terms of research potential and improvement in healthcare services and delivery.^[@B5],[@B82]^ In the past, *telemedicine* and *e-health* were common terms used more broadly to define patient data captured from landlines or videoconferencing interventions. Over the last 10 years, RPM via noninvasive digital technologies has rapidly become a more common way to obtain patient health data. Our systematic literature review is unique in that we identified studies utilizing RPM via noninvasive technologies to investigate the application of these technologies among diverse patient populations and various health conditions.

The majority of studies included in this systematic review were RCTs of multicomponent technologies in adult populations. Chronic conditions, including respiratory diseases, weight management, metabolic diseases, and cardiovascular diseases, were the focus of noninvasive digital RPM interventions, which indicates the high burden of chronic disease to the health system. Healthcare settings where a physician or nurse collected and provided feedback to the patient regarding the remotely captured data represented the majority of studies; the data feedback loop is a critical component in ensuring that RPM interventions have a high impact on patient health. Due to the descriptive nature of many of the included studies, health outcomes were categorized as positive, negative, or neutral (rather than individual measures of efficacy or effectiveness) to allow for an assessment of the overall trends in improving outcomes across all the technologies. The health outcomes data reported were classified as mostly positive across all of the included studies. Key outcomes included self-management (i.e., taking blood pressure or tracking weight) shown to help symptoms severity and reduce patient visits and/or hospitalizations,^[@B59],[@B67],[@B79]^ as well as quality of life improvement through activation of self-care behaviors.^[@B22],[@B66]^

A limited number of studies have reported healthcare data on the use of RPM via noninvasive digital technologies in the peer-reviewed literature.^[@B83],[@B84]^ Large-scale implementation is challenging in terms of budget (cost of technology and infrastructure to monitor), educating patients in the use of devices, training providers in the collection and interpretation of results, as well as incorporation of the remote patient data into routine clinical practice.^[@B6],[@B84],[@B85]^ To our knowledge, this study is the first systematic review of RPM using noninvasive digital technologies examining any disease or condition spanning the last decade in the peer-reviewed literature. Similar to systematic reviews of other clinical interventions, we purposely applied the same level of methodological rigor, including quality appraisal, to identify the best available evidence to describe the key trends, patient and clinical characteristics, and outcomes measured by these technologies.

Several studies identified gaps that may be addressed by future research, including patient activation and costs. In terms of patient activation, new technologies such as smartphones/PDAs not only reduce resources in terms of patient visits but they may also promote health-related behavioral changes in patients by delivering convenient and individually tailored interventions.^[@B5],[@B21],[@B86]^ Furthermore, wireless transmission of patient data directly from devices to a centralized system may be the most cutting-edge technology available.^[@B5]^ These devices (typically biosensors or wearables) reduce patient burden and human error associated with manual entry and data transmission from the peripheral devices to the centralized data system.

In this systematic review, the few studies that reported cost outcomes found many costs associated with utilizing an RPM technology to be neutral or cost-saving compared with the control group.^[@B29],[@B43],[@B60],[@B66],[@B69],[@B81]^ The majority of patients in studies reporting cost were \>50 years of age, which may be due to the value of RPM data being highest among seniors due to the demand on provider\'s time.^[@B15],[@B87]^ The growing interest in RPM for programs such as Medicare is expected to increase as the senior U.S. population grows and future studies may begin to explore cost-savings associated with these technologies.^[@B88]^ However, a recent RCT study found little evidence of differences in short-term healthcare utilization and costs between patients with chronic conditions monitored through mobile health or digital medicine technology versus standard disease management.^[@B89]^ To better understand the appropriate use of RPM interventions using noninvasive digital technologies, future research should explore long-term healthcare utilization and costs in various patient populations such as those with chronic diseases.

Limitations {#s011}
===========

There are a few limitations that should be noted for our systematic review. The search string was very specific and may not have captured all articles. Although the majority of studies were RCT designs, observational cross-sectional studies were included, but no quality appraisal was performed. These studies are unlikely to impact the overall findings due to the descriptive nature of the results. In addition, the majority of studies were exploratory or pilot designs, with a high degree of variability in the objectives, populations, and outcomes reported; therefore, the information extracted was limited to broad categorization, subject to prespecified definitions, to assess commonality and trends. Many of the studies included in the systematic review enrolled relatively small patient populations; future clinical trials should assess the sample size required to have an adequately powered design and allow for a more generalizable population to assess the effectiveness of RPM technology on the outcomes of interest. In addition, the majority of the included studies reported short trial durations; however, to accurately assess the effectiveness of these technologies, the duration should align with the study objectives and clinical outcomes assessed (e.g., readmission rates). Discretion was used with the "feedback loop/end user" variable as this was not clearly described in many of the articles; however, we still felt it was an important aspect of these interventions and highly relevant to their overall value in healthcare. Many of the studies included only descriptive results; lack of robust measurement on the benefit of RPM on patient outcomes and care delivery was demonstrated. In terms of implementation, most studies did not report whether the data was ultimately added to the health system records, as previously stated this may be due to the exploratory nature of these studies.

Conclusions {#s012}
===========

Despite its potential, the rapid development of technological capabilities in the healthcare field has outpaced the capacity to implement many novel RPM interventions into real-world practice. Hence, scant evidence demonstrating improved health outcomes with noninvasive RPM interventions is available and even fewer studies have demonstrated any cost benefit. Based on this systematic review, there is a key trend toward using multicomponent interventions for the monitoring of chronic conditions in older populations. Further research utilizing robust study designs is needed to assess the efficacy and value of RPM technology for decision makers, developers, researchers, clinicians, and investors. This study will help decision makers better understand the current state of evidence available in peer-reviewed literature and assist in the planning of future studies that could address the existing gaps identified in this systematic review. Large-scale implementation is required to confirm the benefits of RPM across sectors and populations in the health systems and identify the "optimal" patient for maximum utility of RPM. Barriers to implementation should also be assessed, including provider training, data reliability, security, and incorporation of RPM data into routine care.
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For example: Greene et al.^[@B62]^ incorporated data captured from an online social network, accelerometer, and a scale.

For example: Greene et al.^[@B62]^ incorporated data captured from an online social network, accelerometer and a scale.

Positive outcomes example: Allard et al.^[@B20]^ reported that imaging markers of dementia were significantly associated with mobile assessments of semantic memory performance.

Neutral outcomes example: De San Miguel et al.^[@B60]^ reported the telehealth group had nonsignificant reductions in emergency department visits, hospital admissions, and length of stay in comparison with the control group.
